-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Edwards Lifesciences, Raises Price Target to $95

Benzinga·07/25/2025 17:23:36
Listen to the news
Mizuho analyst Anthony Petrone maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $87 to $95.